Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06124326 · ClinicalTrials.gov registry record · NA
A Single Group Study to Evaluate the Effects of a Supplement on Premenstrual Syndrome
A NA study, sponsored by Rael.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06124326 is a NA study that has completed, run by Rael. The registered enrollment target is 40 participants.
The verdict
NCT06124326, a NA study, has completed, sponsored by Rael.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a virtual single-group study that will last three menstrual cycles (approximately 12 weeks). During the first menstrual cycle, participants will take the supplement as needed (pro re nata) when they feel symptoms of PMS, such as cramping or bloating. For the second and third menstrual cycles, Participants will take 2 capsules per day with water for 1 week, starting 4 days before their menstrual cycle and finishing on Day 3 of their cycle. Questionnaires will be completed at the following time points: * Baseline * Day 7 of their first cycle during the trial (After using the product PRN during their period) * 4 days before their second period during the trial (After using the product PRN for the previous month) * Day 3 of their second period during the trial (After using the product for 7 days straight) * Day 3 of their third period of the trial (After using the product for 7 days straight)
Interventions
- DIETARY_SUPPLEMENT Premenstrual Syndrome Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-08-31 |
| Est. Completion | 2024-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06124326
The ClinicalTrials.gov registry entry for NCT06124326 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rael, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Premenstrual Syndrome Supplement is the first listed.
NCT06124326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06124326 about?
NCT06124326 is a clinical study titled "A Single Group Study to Evaluate the Effects of a Supplement on Premenstrual Syndrome". This is a virtual single-group study that will last three menstrual cycles (approximately 12 weeks). During the first menstrual cycle, participants will take the supplement as needed (pro re nata) when they feel symptoms of PMS, such as cramping or bloating. For the second and third menstrual cycles...
What is the current status of trial NCT06124326?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-08-31. Estimated completion is 2024-01-20.
What interventions are being tested in trial NCT06124326?
The interventions under investigation include: Premenstrual Syndrome Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06124326?
This trial is sponsored by Rael, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.